Stay updated on Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Sign up to get notified when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.

Latest updates to the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedRevision history now includes v3.3.2 and removes v3.3.1.SummaryDifference0.1%

- Check21 days agoChange DetectedDifference0.1%

- Check28 days agoChange DetectedThe government funding and NIH operating status notice was removed from the page history view. The notice previously warned that the site may not be up to date and directed users to check the operating status.SummaryDifference0.8%

- Check42 days agoChange DetectedVersion 2025-10-15 includes changes to Recruitment Status, Study Status, and Contacts/Locations for NCT05453799.SummaryDifference0.1%

- Check71 days agoChange Detected- Added a government-funding notice impacting updates and inquiries; NIH Clinical Center status and links; updated operating-status guidance and new version v3.2.0. - Removed older version tag v3.1.0.SummaryDifference13%

- Check78 days agoChange DetectedUpgrade noted: version from v3.0.2 to v3.1.0. No other content changes detected.SummaryDifference0.3%

Stay in the know with updates to Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vudalimab for Anaplastic/Hurthle Thyroid Cancer Clinical Trial page.